Market revenue in 2023 | USD 10.1 million |
Market revenue in 2030 | USD 16.6 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.61% in 2024. Horizon Databook has segmented the China uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, China accounted for the largest share in the uterine manipulation devices market due to the rising awareness about the benefits of uterine manipulation devices, the growing demand for uterine manipulation devices, and the surging cases of cervical cancer. According to the State Council of the People’s Republic of China, about 100,000 women in China are diagnosed with cervical cancer annually.
According to a research study published in 2023, around 31 million obstetrical and gynecological procedures were performed in 2023; whereas in 2019, the obstetrical and gynecological procedures performed were 29.7 million. Hence, the increasing number of gynecological procedures is expected to boost the uterine manipulation devices market in China. The regulatory process for product approvals is less stringent in China compared to other countries, such as the U.S., which facilitates easy entry of advanced products into the market.
In addition, easy availability of resources enables technological advancements at cheaper costs, which has led to an increase in the number of manufacturing facilities in the country. In addition, the constant development of medical infrastructure and increasing investments by government & private players to promote the adoption of safer & cost-effective healthcare solutions are among the factors fueling market growth. Hence, China is anticipated to provide lucrative growth opportunities to market players over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the China uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into China uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account